Did you mean
antibodies

Search results - 509 results

Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?

Source: Lancet Microbe, Volume 3, Issue 12 (2022) Keywords: Antibodies, Bacterial COVID-19 Humans Mycoplasma pneumoniae Pandemics Pneumonia, Mycoplasma Health Topics:  Acute respiratory tract infection ...

Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.

have decreased antibody responses upon vaccination targeting other viral antigens. OBJECTIVES: As real-world data on vaccine responsiveness, we assessed the prevalence of SARS-CoV-2 antibodies among ...

Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients.

anti- S1 IgG antibody levels and SARSC oV-2 50% neutralization titers (NT50) against Wuhan and BA.1 Omicron strains. Cellular immunity was examined by analyzing CD4 + and CD8 + T cell responses against ...

Epidemiological, clinical and radiological characteristics of people with neurocysticercosis in Tanzania-A cross-sectional study.

patients were tested with a novel antibody-detecting point-of-care test for the diagnosis of Taenia solium cysticercosis. All test positives and a subset of test negatives had a further clinical work-up ...

Tick-Borne Encephalitis Virus Prevalence in Sheep, Wild Boar and Ticks in Belgium.

Keywords: Animals Antibodies, Viral Belgium Encephalitis Viruses, Tick-Borne Encephalitis, Tick-Borne prevalence Seroepidemiologic Studies Sheep Sus scrofa Swine Ticks Abstract: Tick-borne encephalitis virus ...

Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up.

incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers (PHCP s). DESIGN: Prospective cohort study with 12 months of follow-up. SETTING: Primary care in Belgium. ...

Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial.

ratio to receive either camostat mesylate or a placebo. Outcomes included change in nasopharyngeal viral load, time to clinical improvement, the presence of neutralizing antibodies, and safety. RESULTS: ...

Porcine Reproductive and Respiratory Syndrome virus (PRRSv): A Cross-Sectional Study on ELISA Seronegative, Multivaccinated Sows

(prevalence–origin–consequences) was not yet investigated. In this study, the prevalence of ELISA non-responders was assessed by measuring PRRS v-specific antibodies in 1400 sows, originating from 70 PRRS v-vaccinating sow herds, ...

Porcine Reproductive and Respiratory Syndrome virus (PRRSv): A Cross-Sectional Study on ELISA Seronegative, Multivaccinated Sows.

Animals Antibodies, Neutralizing Antibodies, Viral cross-sectional studies Enzyme-Linked Immunosorbent Assay Female Porcine Reproductive and Respiratory Syndrome Porcine respiratory and reproductive ...

QR code

QR code for this page URL